Diabetes discovery illuminates path to new drugs

July 25, 2014 by Alvin Powell
Searching for “broken genes” — those whose protective effects come from shutting off and ceasing to function — gives drug companies an important leg up, explained David Altshuler, professor of genetics and medicine at Harvard Medical School. Creating a drug to stop a gene from working is less complicated than creating one to turn a gene on, make it go faster, or change how it functions. During the Broad Institute's summer lecture series, Altshuler was explaining the recent discovery of a genetic mutation that protects against type 2 diabetes. Credit: Rose Lincoln/Harvard Staff Photographer

To David Altshuler, the recent discovery of a genetic mutation that protects against type 2 diabetes offers hope in fighting more than just diabetes.

It also illustrates how using the tools of genetics to hunt for "broken genes" can aid drug discovery, a process that itself is broken, Altshuler said, with new finds scarce despite billions spent on research.

"Almost everything we put into patients fails," said Altshuler, a Harvard Medical School genetics professor. "There's something wrong with what we're doing."

The "broken gene" procedure involves screening large segments of the population for people who should develop a particular disease, but don't. Once found, researchers screen their genomes, comparing the results with the rest of the population, singling out genetic differences that provide the protective effects, and looking specifically for genes that are unexpectedly shut off.

Genes involved in disease, of course, can operate in different ways. In addition to being shut off entirely, they can turn on at the wrong time, shut off at the wrong time, or stay on too long or not long enough.

Altshuler, who is also a researcher at both the Broad Institute of MIT and Harvard and Massachusetts General Hospital, spoke Wednesday at the Broad as part of a summer lecture series. Searching for "broken genes"—those whose protective effects come from shutting off and ceasing to function—gives drug companies an important leg up, he said. Creating a drug to stop a gene from working is less complicated than creating one to turn a gene on, make it go faster, or change how it functions.

The find, announced in March, was conducted by an international consortium led by Altshuler. Researchers screened 150,000 patients and identified several thousand who had risk factors for diabetes—including old age and obesity—and yet hadn't developed the disease. In those people, researchers examined a suite of genes known to be associated with diabetes, finding a mutation in one, called SLC30A8, that stopped it from functioning and that was responsible for the protective effects. Further work showed other mutations of the same gene that, if one copy was inherited, cut the risk of developing 65 percent.

The potential boost from "broken genes" is badly needed, Altshuler said.

Drug development has been bumping along at a discouragingly low pace for decades, he said. Advances in laboratory techniques have greatly reduced the toxicity that caused most drug candidates to fail in past decades, but the number of drugs that successfully make it through clinical trials hasn't budged.

And the major reason is that the vast majority of them just don't work, Altshuler said. Despite better techniques and the development of animal models that supposedly mimic human biology, more than 95 percent of lab-effective candidates are ineffective when attempted in humans, he said.

We still don't understand human biology well enough to fully understand how a drug will work in people, Altshuler said, or even to pick up key biological differences between humans and the lab animals.

In the past, Altshuler said, successful drugs were found by investigating "experiments of nature"—observations of disease outcomes that differed in different populations and that could be traced to a particular physiological trait. For example, Altshuler said, the use of cortisol to treat rheumatoid arthritis came from observations that the condition would improve in patients who developed Cushings' syndrome, marked by too much cortisol, and get worse in those with Addison's disease, marked by too little.

Those kinds of natural experiments not only point the way toward treatment, they provide scientists with assurance that the treatment will be safe, and will work. The tools of genetics have the potential to uncover the same sort of natural experiments, Altshuler said, and provide a pathway to more effective drug discovery.

"We can recognize when a DNA variation breaks a gene and stops its functioning cold," Altshuler said.

Explore further: Study pinpoints protective mutations for type 2 diabetes

Related Stories

Study pinpoints protective mutations for type 2 diabetes

March 2, 2014
An international team led by researchers at the Broad Institute and Massachusetts General Hospital (MGH) has identified mutations in a gene that can reduce the risk of developing type 2 diabetes, even in people who have risk ...

Research unearths genetic risk factor for type 2 diabetes in Latin American populations

June 10, 2014
In the largest study of its kind published to date, an international team of researchers in Mexico and the United States has discovered a strong genetic risk factor for type 2 diabetes that primarily affects Latin American ...

Raising HDL not a sure route to countering heart disease

May 16, 2012
A new paper published online in The Lancet challenges the assumption that raising a person's HDL — the so-called "good cholesterol" — will necessarily lower the risk of a heart attack. The new research underscores ...

Gene function identified in type 1 diabetes progression

July 23, 2014
IDENTIFYING a genetic weakness that causes type 1 diabetes in children has opened the way for development of a treatment capable of preventing the disease.

Study reveals new genetic risk factor for type 2 diabetes

December 25, 2013
An international team of researchers in Mexico and the United States has uncovered a new genetic clue that contributes to an increased risk of developing type 2 diabetes, particularly the elevated risk among Mexican and other ...

Recommended for you

The 16 genetic markers that can cut a life story short

July 27, 2017
The answer to how long each of us will live is partly encoded in our genome. Researchers have identified 16 genetic markers associated with a decreased lifespan, including 14 new to science. This is the largest set of markers ...

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.